MECOR Program

HomeAboutGlobal Public Health ▶ MECOR Program
ATS MECOR 2.0 Program

MECOR

The American Thoracic Society (ATS) Methods in Epidemiologic, Clinical, and Operations Research (MECOR) Program is a multi-level research methods training course intended for clinicians, investigators, academicians, and public health professionals who primarily work with pulmonary diseases. The objective of the MECOR Program is to prepare current or aspiring investigators, academicians, clinicians and public health practitioners to design and conduct research that is relevant to the needs of the settings in which they work. The overall goal of the MECOR Program is to aid the improvement of global lung health through the development of local, country, and regional lung disease research capacity in low and middle-income countries.


 Program Structure

Hand

During the spring of 2018, the ATS launched MECOR 2.0, which includes a ground-up redesign of the curriculum, course organization, and faculty/mentorship opportunities. The updated program capitalizes and builds upon the program's extensive experience and expertise with the renewed goal that each participant completes the program with a research manuscript ready for publication.  The curriculum utilizes a "flipped classroom" active learning teaching model with seminar style classroom sessions and a focus on one to one instruction with a learning management system available for students, faculty, and alumni.  

The ATS MECOR 2.0 Curriculum is designed to provide training through a series of intensive one week-long classroom-based programs that combine online remote learning activities, lectures, group discussion and individual protocol development time with a mentor over a 2-year period.


Program Information

The ATS MECOR Program Schedule
Contact List for ATS MECOR Country Directors and Co-Directors


ATS MECOR Staff

Fran Du Melle
ATS Chief Global Health

Chris Hughes
ATS Associate Director, Global Health


"Improving global lung health through development of local, country and regional lung disease research capacity"

Last Reviewed: June 2018